Tuuli Lappalainen, PhD Department of Genetic Medicine and Development University of Geneva Medical School CMU / Rue Michel-Servet 1 1211 Geneva 4 Switzerland Tel. +41-(0)22-3795550 tuuli.lappalainen@unige.chOn /15/1112 12:35 PM, Michael Sammeth wrote:
Here some update on the splicing companion outline:
Tentative title:
Splicing Singularities and Population Polymorphisms of Human Transcriptomes
(1) transcriptome composition varies with gene expression
- although gene discovery does not saturate,
most genes of a certain tissue are expressed ubiquitously across individuals and populations
- population-determinant genes (specific from 1 population) show proliferant factors
age of cell line bias, pairwise distances and tree
- differentially expressed genes accumulate for cell surface factors
(2) transcriptome configuration changes by differential splicing (DS)
- most genes show little transcript variability
- most variable genes show enrichment for cell surface terms (?),
but no significant overlap with DE genes (!)
- alternative psi exons (splicing only)
(3) genetic polymorphisms that influence DS
- fraction of variants in splice site regions,
compare to subgenic localization of sQTLs
- classification of splice site variants in 5 distinct groups, characterization:
activating variants differ in allele frequencies, deteriorating vs. neutral/enhancing indicative of psi exons
(4) discovery of novel elements by RNAseq
- intron variants, number of donors/acceptors...weak are predominantly rare in population
- how many novel events, broken down by type, characterization
Bottom line
- the transcriptomes differ not markedly between individuals/populations
- but quantitative (gene expression level) and qualitative (splicing level) differences occur not (only) at random
On Thu, Nov 15, 2012 at 5:54 AM, Tuuli Lappalainen <Tuuli.Lappalainen@unige.ch> wrote:
Hello all,
We'll have an RNAseq analysis group TC today at 2pm CET. Apologies for the late notice.
I hope many of you can attend since it's been a while due to me traveling; there are a number of important things to discuss:
- updates from Santiago de Chile
- updates from ASHG
- outline, timeline and action items for the main paper
- outlines, timelines and action items for the companion papers
- analysis updates
- AOB
Call details:
Germany +49 692 573 804 41
Netherlands +31 108 920 271
Spain +34 931 816 661
Sweden +46 840 309 949
Switzerland +41 58 262 07 22
United Kingdom +44 203 370 57 19
United States +1 646 381 08 89
Access code: 611683
best,
Tuuli
-- Tuuli Lappalainen, PhD Department of Genetic Medicine and Development University of Geneva Medical School CMU / Rue Michel-Servet 1 1211 Geneva 4 Switzerland Tel. +41-(0)22-3795550 tuuli.lappalainen@unige.ch
_______________________________________________
Geuvadis_rna_analysis mailing list
Geuvadis_rna_analysis@lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_rna_analysis
_______________________________________________ Geuvadis_rna_analysis mailing list Geuvadis_rna_analysis@lists.crg.es http://davinci.crg.es/mailman/listinfo/geuvadis_rna_analysis